Apollomics, Inc. (APLM): Earnings growth forecast for next year
High clinical trial costs in the US and China are limiting the scaling of Apollomics, Inc. (APLM). The current consensus EPS growth forecast for next year demonstrates a trend in expectations, where the 0.00 level reflects the current magnitude. Stable margins are supported by patent protection for unique oncology drugs. Global physician confidence and the brand's scientific authority in Asia and America confirm the potential for therapies targeting specific mutations.
Comprehensive metric breakdowns and analytics for Apollomics (APLM)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book capitalization indicators:
- debt and liquidity details:
- net income and valuation ratios data:
APLM - Net Financial Result|Projected Future Earnings Apollomics, Inc.|APLM - Price to Earnings Ratio|Future Price to Earnings Apollomics Inc.|APLM - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Apollomics|APLM - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Apollomics|APLM - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months apollomicsinc.com|APLM - Earnings per share growth this year|Earnings growth forecast for next year Apollomics, Inc.
Summary company analysis:APLM, Apollomics, Inc.
This indicator measures expected earnings per share (EPS) dynamics, reflecting market expectations regarding business efficiency. By analyzing the consensus forecast for forward-looking EPS growth rates, investors gain a real-time assessment of the market's reaction to fundamental changes prior to the release of official reports. The high sensitivity of this metric allows for an evaluation of how the robotization of biochemical screening at Apollomics, Inc. (APLM) accelerates preclinical research and impacts future profitability.
Competitors of Apollomics, Inc.
ONC (BeiGene Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Corp HALO|Earnings growth forecast for next year RVMD|Earnings growth forecast for next year ascentage.com (AAPG)|Net earnings per share growth forecast for next year CG Oncology CGON|URGN (UroGen Pharma Ltd) - Net earnings per share change forecast for next year|BCAX - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Personalis Genomics|Erasca, Inc. (ERAS) - Net earnings per share growth forecast for next year|DCTH (delcath.com) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Y-mAbs Therapeutics, Inc.|Net earnings per share growth forecast for next year AURA|Net earnings per share growth forecast for next year Candel Therapeutics (CADL)|ARAY - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year SELLAS Life Sciences Group SLS|ACTU - Expected earnings per share growth for next year|Citius Oncology - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year TuHURA Biosciences, Inc. HURA|TARA: Earnings growth forecast for next year|Expected earnings per share growth for next year Fate Pharma|Net earnings per share growth forecast for next year Aadi Bioscience, Inc.|TScan (TCRX) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year CSBR (Champions Oncology)|XBIT (xbiotech.com) - Expected earnings per share trend next year|Earnings growth forecast for next year CVM (CEL-SCI)|Consensus forecast of earnings per share growth for next year OS Therapies, Inc. (OSTX)|RADX - Net earnings per share growth forecast for next year|ARTV (Artiva Biotherapeutics, Inc.) - Projected earnings per share growth rate for next year|ANL: Earnings growth forecast for next year|Expected earnings per share growth for next year Veru Inc|Expected earnings per share growth for next year TPST|Xilio (XLO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year RENB|Earnings growth forecast for next year muraloncology.com (MURA)|Net earnings per share growth forecast for next year Kairos Pharma KAPA|OKUR (OnKure Therapeutics, Inc.) - Net earnings per share change forecast for next year|GDTC - Net earnings per share growth forecast for next year|CRIS: Net earnings per share growth forecast for next year|Tharimmune, Inc. (THAR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Advanced Biomed|GNPX (Genprex) - Earnings growth forecast for next year|Expected earnings per share growth for next year Calidi Bio (CLDI)|Earnings growth forecast for next year SBFM|Earnings growth forecast for next year xeneticbio.com (XBIO)|Net earnings per share growth forecast for next year Salarius Pharmaceuticals SLRX|PPBT: Projected earnings per share growth rate for next year|AON - Earnings growth forecast for next year|BeiGene Ltd. (BGNE) - Expected earnings per share growth for next year|CKPT: Earnings growth forecast for next year|Expected net earnings per share growth next year elevationoncology.com (ELEV)|Net earnings per share growth forecast for next year iCAD Inc.|IKNA: Expected earnings per share trend next year|Expected earnings per share growth for next year NTBL (Notable Labs)|VIRX (viracta.com) - Expected earnings per share trend next year|Earnings growth forecast for next year MOR (MorphoSys Corp)|NAYA - Expected earnings per share growth for next year|AAPGV: Expected earnings per share growth for next year
